The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
4,800 jobs Number of planned job losses
Announcement Date
17 November 2010
Employment effect (start)
18 November 2010
Foreseen end date
31 December 2012
Description
The Switzerland-based pharmaceutical company Roche has announced that it is to reduce its workforce by 4,800 positions over the next two years. The largest reductions will be in sales, marketing and manufacturing.
The European factories in Mannheim and Kulmbach (Germany) will be heavily affected. Also, plants in Graz (Austria) and Burgdorf (Switzerland) will be closed. The redundancies are part of the ‘Operational Excellence Program' of the pharmaceutical company, aiming at reducing costs.
On top of the job reductions, 800 jobs will be transferred to other Roche sites and 700 positions outsourced to third parties. Combination of announced job reductions and transfers will affect 6,300 positions.
Sources
17 November 2010: Roche announcement (www.roche.com)
Eurofound (2010), Roche, Internal restructuring in World, factsheet number 71189, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/71189.